Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.
Donika PlykuEsther MenaSteven P RoweMartin A LodgeZsolt SzaboSteve Y ChoMartin G PomperGeorge SgourosRobert F HobbsPublished in: European journal of nuclear medicine and molecular imaging (2018)
18F-DCFPyL dosimetry in nine patients was obtained using novel models for the lacrimal and salivary glands, two organs with potentially dose-limiting uptake for therapy and diagnosis which lacked pre-existing models.